Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Carcinoma, Hepatocellular 3Lymphoma, Non-Hodgkin 2Uterine Cervical Neoplasms 1Solid Tumor, Unspecified, Adult 1Smoking Cessation 1Recurrence 1Nose Neoplasms 1Neoplasms 1Multiple Pulmonary Nodules 1Melanoma 1Lymphoproliferative Disorders 1Lymphomatoid Granulomatosis 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Liver Neoplasms 1Liver Cirrhosis 1Hematologic Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Endometrial Neoplasms 1Cancer Diagnosis 1Burkitt Lymphoma 1Bronchiolitis Obliterans Syndrome 1Biliary Tract Neoplasms 1

Interventions

Tomography, X-Ray Computed 1Radiotherapy 1Radionuclide Imaging 1Positron-Emission Tomography 1Ibuprofen 1Hydroxyurea 1Fluorouracil 1Electrocardiography 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nose Neoplasms × Tomography, X-Ray Computed × Clear all
NCT05012098 2025-08-08

Phase 2 Study of Bintrafusp Alfa in Recurrent/Metastatic Olfactory Neuroblastoma (BARON).

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 14 charts
CNS

Nose Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡